A pharmaceutical treatment for advanced neuroendocrine tumors and certain cancers including kidney, liver, pancreas, thyroid, prostate, and breast cancers.

An investigational oral treatment targeting rare liver diseases, including primary biliary cholangitis and primary sclerosing cholangitis, aimed at improving symptoms and disease progression.